arrow
L

Laura Diluvio

University of Rome Tor Vergata
H指数:19
被引数:1,412

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study
2026-09-010
PRE
Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series

Tildrakizumab作为代谢合并症和银屑病患者的早期银屑病关节炎的潜在选择:一项病例系列研究

2025-10-010
OAAI
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results

巴瑞替尼在严重斑秃中的有效性与安全性:48周结果

2025-09-230
PRE
Effectiveness of Baricitinib in Alopecia Areata Patients With a Current Episode Lasting Longer Than 8 Years: An Italian Multicenter Real-Life Experience in the Lazio Region

巴瑞替尼在病程超过8年的斑秃患者中的有效性:意大利拉齐奥大区多中心真实世界研究经验

2025-03-120
PRE
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study
2024-09-090
PRE
Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
2024-08-160
OAAI
Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment

用JAK抑制剂治疗的斑秃患者的感染事件: 负担低且对持续治疗的影响最小

2024-05-080
PRE
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study

Dupilumab治疗6-11岁儿童特应性皮炎: 一项多中心、现实生活研究

2022-08-2744
OAAI